Schemmerhofen, Germany

Ralf Richard H Lotz

This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharma Kg. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ralf Richard H Lotz. Retrieved from https://idiyas.com/inventor/ralf-richard-h-lotz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ralf Richard H Lotz: Innovator in Pharmaceutical Chemistry

Introduction

Ralf Richard H Lotz is a notable inventor based in Schemmerhofen, Germany. He has made significant contributions to the field of pharmaceutical chemistry. His work focuses on developing new compounds that can be utilized in medical applications.

Latest Patents

Ralf Lotz holds a patent for "Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines." This patent relates to new substituted 3-phenoxy- or 3-phenylalkyloxy-2-phenyl-propylamines of general formula 1. The patent also details processes for preparing these compounds and their use as pharmaceutical compositions. He has 1 patent to his name.

Career Highlights

Ralf Lotz is currently employed at Boehringer Ingelheim Pharma KG, a leading global pharmaceutical company. His role involves research and development of innovative pharmaceutical solutions. His expertise in chemistry has been instrumental in advancing the company's product offerings.

Collaborations

Throughout his career, Ralf Lotz has collaborated with several esteemed colleagues, including Uwe Pschorn and Helmut Ensinger. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Ralf Richard H Lotz is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in the field. His contributions continue to impact the development of new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…